Hyderabad, November 25, 2018: Unichem Laboratories Limited (‘Unichem’) today announced that the company has entered into an agreement to acquire 20% equity stake in the API and intermediate business of Hyderabad based Optimus group (‘Optimus’).
The transaction will give Unichem access to Optimus’ US FDA approved API manufacturing facilities, and at the same time, Optimus will gain from the extensive knowledge base and industry best practices of Unichem, making the deal a win-win for both Unichem and Optimus.
Trans-Continental Capital Advisors Private Limited (‘TCCA’) and Genesis Management Consultancy Services Private Limited (‘GMCS’) acted as financial advisors to the transaction. TCCA, a Mumbai based advisory firm has recently acted as an advisor in the INR 500 crores worth acquisition of Kimplas Piping Systems by Germany’s Norma group.
Corporate Comm India(CCI NewsWire)
- This specialized division empowers patients with neurological disorders to reclaim their mobility through a…
SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…
Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…
DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…
Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…
Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…